TOVX
Theriva Biologics, Inc.
Company overview
- Market capitalization
- $9.94M
- Employees
- 15
- Latest publication
- 2026-09-29
About Theriva Biologics, Inc.
Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States. Its lead product candidate, VCN-01 (zabilugene almadenorepvec), a clinical stage oncolytic human adenovirus that is in Phase 1 clinical trials and Phase 2 VIRAGE trial for patients with pancreatic cancer, head and neck squamous cell carcinoma, ovarian cancer, colorectal cancer, and retinoblastoma. The company also develops VCN-11 for treating solid tumors; SYN-004 (ribaxamase), an oral capsule prophylactic therapy that is in Phase 1b/2a clinical trials for the prevention of acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant (HCT); and SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP) for multiple gastrointestinal and metabolic indications. In addition, it develops clinical stage products, such as SYN-006 to prevent aGVH, clostridioides difficile infection, and microbiome damage in patients treated with carbapenem antibiotics; and SYN-007 for preventing antibiotic associated diarrhea with oral ß-lactam antibiotics. The company has a license agreement with Rasayana Therapeutics, Inc. to research, develop, manufacture, and commercialize any product that includes SYN-020, as well as a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. Theriva Biologics, Inc. is headquartered in Rockville, Maryland.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 300,000USD | 0USD | 0USD | 0USD | 0USD | 154,000USD | 0USD | 0USD |
| Cost Of Revenue | 24,000USD | 27,000USD | — | 27,000USD | 26,000USD | 27,000USD | 33,000USD | 38,000USD |
| Gross Profit | 276,000USD | -27,000USD | — | -27,000USD | -26,000USD | -27,000USD | -33,000USD | -38,000USD |
| Research Development | 355,000USD | 1,132,000USD | 2,551,000USD | 1,953,000USD | 2,968,000USD | 2,886,000USD | 2,734,000USD | 2,953,000USD |
| Selling General Administrative | 2,072,000USD | 931,000USD | 1,889,000USD | 11,179,000USD | 1,273,000USD | 1,694,000USD | 2,302,000USD | 1,467,000USD |
| Total Operating Expenses | 2,376,000USD | 2,063,000USD | 4,440,000USD | 13,132,000USD | 4,417,000USD | 4,368,000USD | 7,887,000USD | 8,488,000USD |
| Operating Income | -2,100,000USD | -2,063,000USD | -4,440,000USD | -13,132,000USD | -4,417,000USD | -4,395,000USD | -7,887,000USD | -8,488,000USD |
| Interest Income | 82,000USD | 72,000USD | 65,000USD | 54,000USD | 96,000USD | 138,000USD | 158,000USD | 173,000USD |
| Net Interest Income | 82,000USD | 72,000USD | 65,000USD | 54,000USD | 96,000USD | 138,000USD | 158,000USD | 173,000USD |
| Income Before Tax | -2,044,000USD | -1,996,000USD | -4,361,000USD | -13,058,000USD | -4,324,000USD | -4,447,000USD | -7,726,000USD | -8,316,000USD |
| Tax Provision | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Income | -2,044,000USD | -1,996,000USD | -4,361,000USD | -13,058,000USD | -4,324,000USD | -4,447,000USD | -7,726,000USD | -8,316,000USD |
| Net Income From Continuing Ops | -2,044,000USD | -1,996,000USD | -4,361,000USD | -13,058,000USD | -4,324,000USD | -4,447,000USD | -7,726,000USD | -8,316,000USD |
| Ebit | -2,100,000USD | -2,063,000USD | -4,361,000USD | -13,132,000USD | -4,396,000USD | -4,447,000USD | -5,036,000USD | -4,420,000USD |
| Ebitda | -2,076,000USD | -2,036,000USD | -4,333,000USD | -13,105,000USD | -4,370,000USD | -4,420,000USD | -5,003,000USD | -4,382,000USD |
| Depreciation And Amortization | 24,000USD | 27,000USD | 28,000USD | 27,000USD | 26,000USD | 27,000USD | 33,000USD | 38,000USD |
| Reconciled Depreciation | 24,000USD | 27,000USD | 28,000USD | 27,000USD | 26,000USD | 27,000USD | 33,000USD | 38,000USD |
| Total Other Income Expense Net | 56,000USD | 67,000USD | 79,000USD | 74,000USD | 93,000USD | -52,000USD | 161,000USD | 172,000USD |
| Income Tax Expense | — | 1,510,000USD | — | — | — | 1,000USD | — | — |
| Selling And Marketing Expenses | — | — | — | — | 155,000USD | 39,000USD | — | 158,000USD |
| Interest Expense | — | — | — | — | — | 697,000USD | — | — |
| Unclassified Operating Expenses | — | — | — | — | — | — | 2,851,000USD | 3,910,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 108,000USD | 137,000USD | 135,000USD | 268,000USD | 87,000USD | 201,000USD | 240,000USD | 272,000USD |
| Gross Profit | -108,000USD | -137,000USD | -135,000USD | -268,000USD | -87,000USD | -201,000USD | -240,000USD | -272,000USD |
| Research Development | 8,604,000USD | 12,031,000USD | 14,311,000USD | 11,723,000USD | 7,800,000USD | 5,131,000USD | 11,083,000USD | 11,844,000USD |
| Selling General Administrative | 15,447,000USD | 7,396,000USD | 7,156,000USD | 6,998,000USD | 6,474,000USD | 4,820,000USD | 4,379,000USD | 5,727,000USD |
| Unclassified Operating Expenses | -9,139,000USD | 6,919,000USD | — | 2,291,000USD | — | — | — | — |
| Total Operating Expenses | 14,912,000USD | 26,346,000USD | 21,431,000USD | 21,581,000USD | 14,274,000USD | 10,160,000USD | 15,663,000USD | 17,571,000USD |
| Operating Income | -15,020,000USD | -26,346,000USD | -21,431,000USD | -21,581,000USD | -14,274,000USD | -10,160,000USD | -15,663,000USD | -17,571,000USD |
| Interest Income | 287,000USD | 697,000USD | 1,442,000USD | 512,000USD | 6,000USD | 44,000USD | 283,000USD | 67,000USD |
| Net Interest Income | 287,000USD | 697,000USD | 1,442,000USD | 512,000USD | 6,000USD | 44,000USD | 283,000USD | 67,000USD |
| Income Before Tax | -23,739,000USD | -25,653,000USD | -19,989,000USD | -21,110,000USD | -14,268,000USD | -10,116,000USD | -15,380,000USD | -13,421,000USD |
| Income Tax Expense | 1,510,000USD | — | -1,640,000USD | -1,425,000USD | -94,000USD | -117,000USD | -360,000USD | -4,204,000USD |
| Tax Provision | 0USD | 0USD | -1,774,000USD | -1,425,000USD | 0USD | — | — | — |
| Net Income | -25,249,000USD | -25,653,000USD | -18,349,000USD | -19,685,000USD | -14,174,000USD | -10,043,000USD | -15,303,000USD | -13,367,000USD |
| Net Income From Continuing Ops | -23,739,000USD | -25,653,000USD | -19,309,000USD | -19,685,000USD | -14,268,000USD | -10,116,000USD | -15,380,000USD | -13,421,000USD |
| Ebit | -15,020,000USD | -19,427,000USD | -22,091,000USD | -19,290,000USD | -14,274,000USD | -10,160,000USD | -15,663,000USD | -17,571,000USD |
| Ebitda | -14,912,000USD | -19,290,000USD | -21,956,000USD | -19,205,000USD | -14,187,000USD | -9,959,000USD | -15,423,000USD | -17,299,000USD |
| Depreciation And Amortization | 108,000USD | 137,000USD | 135,000USD | 85,000USD | 87,000USD | 201,000USD | 240,000USD | 272,000USD |
| Reconciled Depreciation | 108,000USD | 137,000USD | 121,000USD | 85,000USD | 87,000USD | 201,000USD | 240,000USD | 272,000USD |
| Total Other Income Expense Net | -8,719,000USD | 693,000USD | 1,442,000USD | 471,000USD | 6,000USD | 44,000USD | 283,000USD | 4,150,000USD |
| Selling And Marketing Expenses | — | — | 624,000USD | 569,000USD | — | 209,000USD | 201,000USD | — |
| Interest Expense | — | — | — | 430,000USD | 93,000USD | — | — | — |
| Minority Interest | — | — | — | 0USD | 1,000USD | 73,000USD | 77,000USD | 54,000USD |
| Net Income Applicable To Common Shares | — | — | — | -19,685,000USD | -23,189,000USD | -12,557,000USD | -16,076,000USD | -25,291,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 38,248,000USD | 38,239,000USD | 30,836,000USD | 35,830,000USD | 32,161,000USD | 35,352,000USD | 40,108,000USD | 42,390,000USD |
| Intangible Assets | 19,225,000USD | 19,619,000USD | 19,614,000USD | 19,624,000USD | 18,084,000USD | 17,358,000USD | 18,651,000USD | 19,179,000USD |
| Other Current Assets | 2,326,000USD | 576,000USD | 551,000USD | 744,000USD | 766,000USD | 1,349,000USD | 1,122,000USD | 1,192,000USD |
| Total Liab | 22,849,000USD | 22,856,000USD | 24,098,000USD | 25,207,000USD | 16,664,000USD | 16,285,000USD | 15,473,000USD | 14,744,000USD |
| Total Stockholder Equity | 15,399,000USD | 15,383,000USD | 6,738,000USD | 10,623,000USD | 15,497,000USD | 19,067,000USD | 24,635,000USD | 27,646,000USD |
| Other Current Liab | 9,111,000USD | 8,394,000USD | 9,533,000USD | 11,119,000USD | 7,092,000USD | 6,126,000USD | 5,961,000USD | 5,338,000USD |
| Common Stock | 45,000USD | 34,000USD | 9,000USD | 8,000USD | 3,000USD | 3,000USD | 3,000USD | 23,000USD |
| Capital Stock | 45,000USD | 34,000USD | 9,000USD | 8,000USD | 3,000USD | 3,000USD | 3,000USD | 1,769,000USD |
| Retained Earnings | -360,754,000USD | -358,710,000USD | -356,714,000USD | -352,353,000USD | -339,295,000USD | -334,971,000USD | -330,525,000USD | -322,799,000USD |
| Cash | 14,431,000USD | 13,056,000USD | 7,528,000USD | 12,120,000USD | 10,014,000USD | 11,609,000USD | 16,409,000USD | 16,593,000USD |
| Cash And Short Term Investments | 14,431,000USD | 13,056,000USD | 7,528,000USD | 12,120,000USD | 10,014,000USD | 11,609,000USD | 16,409,000USD | 16,593,000USD |
| Total Current Assets | 16,757,000USD | 17,467,000USD | 9,903,000USD | 14,743,000USD | 12,476,000USD | 16,281,000USD | 19,533,000USD | 19,715,000USD |
| Total Current Liabilities | 10,264,000USD | 10,014,000USD | 11,003,000USD | 12,394,000USD | 8,148,000USD | 7,585,000USD | 7,323,000USD | 6,848,000USD |
| Net Debt | -12,364,000USD | -10,427,000USD | -4,766,000USD | -9,229,000USD | -7,159,000USD | -10,044,000USD | -14,670,000USD | -14,763,000USD |
| Short Term Debt | 545,000USD | 606,000USD | 675,000USD | 668,000USD | 619,000USD | 600,000USD | 606,000USD | 575,000USD |
| Short Long Term Debt | 35,000USD | 57,000USD | 57,000USD | 56,000USD | 51,000USD | 61,000USD | 65,000USD | 62,000USD |
| Short Long Term Debt Total | 2,067,000USD | 2,629,000USD | 2,762,000USD | 2,891,000USD | 2,855,000USD | 1,565,000USD | 1,739,000USD | 1,830,000USD |
| Long Term Debt | 1,626,000USD | 1,671,000USD | 1,654,000USD | 1,639,000USD | 1,504,000USD | 92,000USD | 98,000USD | 93,000USD |
| Accounts Payable | 608,000USD | 1,014,000USD | 795,000USD | 607,000USD | 437,000USD | 859,000USD | 756,000USD | 935,000USD |
| Property Plant Equipment Net | 2,140,000USD | 1,025,000USD | 1,191,000USD | 1,335,000USD | 1,424,000USD | 1,542,000USD | 1,742,000USD | 1,855,000USD |
| Property Plant Equipment Gross | 3,121,000USD | 1,991,000USD | 2,179,000USD | 2,359,000USD | 2,397,000USD | 2,477,000USD | 2,669,000USD | 2,739,000USD |
| Accumulated Other Comprehensive Income | 377,000USD | 755,000USD | 763,000USD | 793,000USD | -524,000USD | -1,178,000USD | 112,000USD | -709,000USD |
| Common Stock Shares Outstanding | 41,072,725shares | 12,140,697shares | 9,676,521shares | 6,752,953shares | 2,782,449shares | 1,348,126shares | 1,134,391shares | 775,736shares |
| Non Current Assets Total | 21,491,000USD | 20,772,000USD | 20,933,000USD | 21,087,000USD | 19,685,000USD | 19,071,000USD | 20,575,000USD | 22,675,000USD |
| Non Current Liabilities Total | 12,585,000USD | 12,842,000USD | 13,094,999USD | 12,813,000USD | 8,516,000USD | 8,700,000USD | 8,150,000USD | 7,896,000USD |
| Non Current Liabilities Other | 8,838,000USD | 10,004,000USD | 10,793,000USD | 10,160,000USD | 5,685,000USD | 6,973,000USD | 6,788,000USD | 6,201,000USD |
| Non Currrent Assets Other | 19,351,000USD | 82,000USD | 82,000USD | 128,000USD | 177,000USD | 171,000USD | 182,000USD | 77,000USD |
| Net Working Capital | 6,493,000USD | 7,453,000USD | -1,100,000USD | 2,349,000USD | 4,328,000USD | 8,696,000USD | 12,210,000USD | 12,867,000USD |
| Unclassified Non Current Assets | -19,225,000USD | — | — | — | — | — | — | — |
| Unclassified Non Current Liabilities | 2,121,000USD | 1,167,000USD | — | 1,014,000USD | 1,327,000USD | 1,635,000USD | 1,264,000USD | 1,602,000USD |
| Unclassified Equity | 375,686,000USD | 373,270,000USD | 362,671,000USD | 362,167,000USD | 355,310,000USD | 355,210,000USD | 355,042,000USD | 349,362,000USD |
| Net Receivables | — | 3,835,000USD | 1,824,000USD | 1,879,000USD | 1,696,000USD | 3,323,000USD | 2,002,000USD | 1,930,000USD |
| Good Will | — | — | — | — | — | 0USD | 0USD | 1,465,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | 3,489,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | — | -3,551,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 38,239,000USD | 35,352,000USD | 55,219,000USD | 71,861,000USD | 70,365,000USD | 8,410,000USD | 17,235,000USD | 30,141,000USD |
| Intangible Assets | 19,619,000USD | 17,358,000USD | 19,755,000USD | 19,150,000USD | — | — | — | — |
| Other Current Assets | 576,000USD | 1,349,000USD | 2,286,000USD | 3,503,000USD | 1,533,000USD | 1,238,000USD | 1,378,000USD | 461,000USD |
| Total Liab | 22,856,000USD | 16,285,000USD | 15,522,000USD | 17,297,000USD | 4,957,000USD | 3,152,000USD | 5,748,000USD | 3,686,000USD |
| Total Stockholder Equity | 15,383,000USD | 19,067,000USD | 39,697,000USD | 54,564,000USD | 65,408,000USD | 8,031,000USD | 14,365,000USD | 29,364,000USD |
| Other Current Liab | 8,394,000USD | 6,126,000USD | 5,418,000USD | 5,872,000USD | 2,906,000USD | 1,793,000USD | 2,711,000USD | 2,350,000USD |
| Common Stock | 34,000USD | 3,000USD | 18,000USD | 16,000USD | 13,000USD | 29,000USD | 17,000USD | 15,000USD |
| Capital Stock | 34,000USD | 3,000USD | 2,752,000USD | 2,750,000USD | 132,000USD | 15,304,000USD | 17,322,000USD | 18,071,000USD |
| Retained Earnings | -358,710,000USD | -334,971,000USD | -309,318,000USD | -290,969,000USD | -271,284,000USD | -248,094,000USD | -235,537,000USD | -219,461,000USD |
| Cash | 13,056,000USD | 11,609,000USD | 23,177,000USD | 41,786,000USD | 67,325,000USD | 6,227,000USD | 15,045,000USD | 28,918,000USD |
| Cash And Short Term Investments | 13,056,000USD | 11,609,000USD | 23,177,000USD | 41,786,000USD | 67,325,000USD | 6,227,000USD | 15,045,000USD | 28,918,000USD |
| Total Current Assets | 17,467,000USD | 16,281,000USD | 27,403,000USD | 45,520,000USD | 68,858,000USD | 7,934,000USD | 16,426,000USD | 29,511,000USD |
| Total Current Liabilities | 10,014,000USD | 7,585,000USD | 6,738,000USD | 7,060,000USD | 3,554,000USD | 2,966,000USD | 5,275,000USD | 3,384,000USD |
| Net Debt | -10,427,000USD | -10,044,000USD | -21,023,000USD | -40,105,000USD | -65,798,000USD | -5,754,000USD | -14,323,000USD | -28,918,000USD |
| Short Term Debt | 606,000USD | 600,000USD | 550,000USD | 273,000USD | 124,000USD | 287,000USD | 249,000USD | — |
| Short Long Term Debt | 57,000USD | 61,000USD | 63,000USD | 57,000USD | — | — | — | — |
| Short Long Term Debt Total | 2,629,000USD | 1,565,000USD | 2,154,000USD | 1,681,000USD | 1,527,000USD | 473,000USD | 722,000USD | — |
| Long Term Debt | 1,671,000USD | 92,000USD | 162,000USD | 221,000USD | — | — | — | — |
| Net Receivables | 3,835,000USD | 3,323,000USD | 1,940,000USD | 231,000USD | — | 469,000USD | 3,000USD | — |
| Accounts Payable | 1,014,000USD | 859,000USD | 770,000USD | 915,000USD | 524,000USD | 886,000USD | 2,315,000USD | 1,034,000USD |
| Property Plant Equipment Net | 1,025,000USD | 1,542,000USD | 2,181,000USD | 1,544,000USD | 1,484,000USD | 453,000USD | 786,000USD | 607,000USD |
| Property Plant Equipment Gross | 1,991,000USD | 2,477,000USD | 3,183,000USD | 2,409,000USD | 1,484,000USD | 1,542,000USD | 1,673,000USD | — |
| Accumulated Other Comprehensive Income | 755,000USD | -1,178,000USD | 32,000USD | -679,000USD | — | — | — | 0USD |
| Common Stock Shares Outstanding | 12,140,697shares | 1,348,126shares | 644,280shares | 613,090shares | 12,187,504shares | 1,901,136shares | 1,643,820shares | 623,244shares |
| Non Current Assets Total | 20,772,000USD | 19,071,000USD | 27,816,000USD | 26,341,000USD | 1,507,000USD | 476,000USD | 809,000USD | 630,000USD |
| Non Current Liabilities Total | 12,842,000USD | 8,700,000USD | 8,784,000USD | 10,237,000USD | 1,403,000USD | 186,000USD | 473,000USD | 302,000USD |
| Non Current Liabilities Other | 10,004,000USD | 6,973,000USD | 6,274,000USD | 7,211,000USD | — | — | — | — |
| Non Currrent Assets Other | 82,000USD | 171,000USD | 78,000USD | -3,146,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD |
| Net Working Capital | 7,453,000USD | 8,696,000USD | 20,665,000USD | 38,460,000USD | 65,304,000USD | 4,968,000USD | 11,151,000USD | 26,127,000USD |
| Unclassified Non Current Liabilities | 1,167,000USD | 1,635,000USD | 2,348,000USD | -25,174,000USD | 1,403,000USD | — | — | — |
| Unclassified Equity | 373,270,000USD | 355,210,000USD | 346,213,000USD | 343,446,000USD | 336,547,000USD | 240,792,000USD | 232,563,000USD | 230,739,000USD |
| Good Will | — | 0USD | 5,700,000USD | 5,525,000USD | 0USD | — | — | — |
| Current Deferred Revenue | — | — | 2,868,000USD | — | — | — | — | — |
| Unclassified Current Liabilities | — | — | -2,931,000USD | — | — | — | — | — |
| Deferred Long Term Liab | — | — | — | 19,150,000USD | — | — | — | — |
| Other Liab | — | — | — | 8,829,000USD | — | — | — | 302,000USD |
| Other Assets | — | — | — | 19,272,000USD | 0USD | 23,000USD | 23,000USD | 23,000USD |
| Inventory | — | — | — | -231,000USD | — | — | 1USD | — |
| Net Tangible Assets | — | — | — | 46,305,000USD | 65,408,000USD | -7,244,000USD | -2,940,000USD | 11,308,000USD |
| Unclassified Non Current Assets | — | — | — | -19,150,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -2,044,000USD | -1,996,000USD | -4,361,000USD | -13,058,000USD | -4,324,000USD | -4,447,000USD | -7,726,000USD | -8,316,000USD |
| Depreciation | 24,000USD | 27,000USD | 28,000USD | 27,000USD | 26,000USD | 27,000USD | 33,000USD | 38,000USD |
| Stock Based Compensation | 135,000USD | 153,000USD | 228,000USD | 173,000USD | 100,000USD | 162,000USD | 177,000USD | 172,000USD |
| Other Non Cash Items | -247,000USD | 892,000USD | 540,000USD | 9,012,000USD | 141,000USD | 302,000USD | 3,575,000USD | 3,884,000USD |
| Change In Working Capital | -324,000USD | -1,549,000USD | -526,000USD | -693,000USD | -290,000USD | -516,000USD | 253,000USD | 991,000USD |
| Total Cash From Operating Activities | -2,456,000USD | -2,882,000USD | -4,319,000USD | -4,712,000USD | -4,756,000USD | -4,691,000USD | -3,913,000USD | -3,452,000USD |
| Capital Expenditures | 0USD | 0USD | -19,000USD | -16,000USD | 0USD | 0USD | 0USD | -1,000USD |
| Free Cash Flow | -2,456,000USD | -2,882,000USD | -4,338,000USD | -4,728,000USD | -4,756,000USD | -4,691,000USD | -3,913,000USD | -3,453,000USD |
| Net Borrowings | -49,000USD | 14,000USD | 32,000USD | 46,000USD | 1,345,000USD | 0USD | 0USD | — |
| Total Cash From Financing Activities | 3,866,000USD | 8,458,000USD | -148,000USD | 6,811,000USD | 3,072,000USD | 7,000USD | 3,716,000USD | 1,773,000USD |
| Issuance Of Capital Stock | 2,303,000USD | 6,554,000USD | 279,000USD | 6,690,000USD | 0USD | 7,000USD | 3,716,000USD | — |
| Change In Cash | 1,374,000USD | 5,528,000USD | -4,592,000USD | 2,106,000USD | -1,591,000USD | -4,807,000USD | -180,000USD | -1,668,000USD |
| Begin Period Cash Flow | 13,102,000USD | 7,574,000USD | 12,120,000USD | 10,014,000USD | 11,705,000USD | 16,512,000USD | 16,692,000USD | 18,261,000USD |
| End Period Cash Flow | 14,476,000USD | 13,102,000USD | 7,528,000USD | 12,120,000USD | 10,114,000USD | 11,705,000USD | 16,512,000USD | 16,593,000USD |
| Other Cashflows From Financing Activities | 1,612,000USD | 1,890,000USD | -459,000USD | 71,000USD | 1,727,000USD | 3,723,000USD | 3,716,000USD | 1,773,000USD |
| Investments | — | — | -19,000USD | -16,000USD | 0USD | 0USD | 0USD | -1,000USD |
| Total Cashflows From Investing Activities | — | — | -19,000USD | -16,000USD | — | — | — | -1,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | -3,723,000USD | -3,716,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -23,739,000USD | -25,653,000USD | -18,349,000USD | -19,685,000USD | -14,268,000USD | -10,116,000USD | -15,380,000USD | -13,421,000USD |
| Depreciation | 108,000USD | 137,000USD | 135,000USD | 85,000USD | 87,000USD | 201,000USD | 240,000USD | 272,000USD |
| Stock Based Compensation | 654,000USD | 671,000USD | 552,000USD | 475,000USD | 416,000USD | 350,000USD | 340,000USD | 2,074,000USD |
| Other Non Cash Items | 9,366,000USD | 8,070,000USD | -2,003,000USD | 2,274,000USD | 166,000USD | 178,000USD | 72,000USD | 71,000USD |
| Change In Working Capital | -3,058,000USD | 726,000USD | 2,309,000USD | -806,000USD | 709,000USD | -2,781,000USD | 855,000USD | -2,192,000USD |
| Total Cash From Operating Activities | -16,669,000USD | -16,937,000USD | -18,996,000USD | -19,082,000USD | -12,890,000USD | -12,168,000USD | -13,873,000USD | -17,279,000USD |
| Capital Expenditures | -35,000USD | -1,000USD | -202,000USD | -116,000USD | -14,000USD | -9,000USD | -9,000USD | -7,000USD |
| Free Cash Flow | -16,704,000USD | -16,938,000USD | -19,198,000USD | -19,198,000USD | -12,904,000USD | -12,177,000USD | -13,873,000USD | -17,286,000USD |
| Total Cashflows From Investing Activities | -35,000USD | -1,000USD | -202,000USD | -4,396,000USD | -14,000USD | -9,000USD | -9,000USD | -7,000USD |
| Net Borrowings | 1,437,000USD | -67,000USD | -75,000USD | -1,376,000USD | 0USD | — | — | — |
| Total Cash From Financing Activities | 18,193,000USD | 5,496,000USD | 625,000USD | -1,930,000USD | 74,002,000USD | 3,359,000USD | 3,359,000USD | 29,088,000USD |
| Issuance Of Capital Stock | 13,523,000USD | 5,563,000USD | 2,157,000USD | 2,734,000USD | 65,960,000USD | 3,359,000USD | 0USD | 29,088,000USD |
| Change In Cash | 1,397,000USD | -11,574,000USD | -18,606,000USD | -25,440,000USD | 61,098,000USD | -8,818,000USD | -13,873,000USD | 11,802,000USD |
| Begin Period Cash Flow | 11,705,000USD | 23,279,000USD | 41,885,000USD | 67,325,000USD | 6,227,000USD | 15,045,000USD | 28,918,000USD | 17,116,000USD |
| End Period Cash Flow | 13,102,000USD | 11,705,000USD | 23,279,000USD | 41,885,000USD | 67,325,000USD | 6,227,000USD | 15,045,000USD | 28,918,000USD |
| Other Cashflows From Financing Activities | 3,229,000USD | 5,496,000USD | -1,519,000USD | -266,000USD | 8,042,000USD | -9,000USD | -4,664,000USD | -7,000USD |
| Investments | — | -1,000USD | -237,000USD | -4,396,000USD | -14,000USD | -9,000USD | 0USD | -7,000USD |
| Unclassified Financing Cash Flow | — | -5,496,000USD | 2,219,000USD | — | 65,960,000USD | — | 8,023,000USD | — |
| Sale Purchase Of Stock | — | — | 0USD | -288,000USD | 0USD | — | — | — |
| Unclassified Operating Cash Flow | — | — | -1,640,000USD | -1,425,000USD | — | — | — | -4,083,000USD |
| Change To Liabilities | — | — | — | -385,000USD | -363,000USD | -1,429,000USD | 1,282,000USD | -987,000USD |
| Other Cashflows From Investing Activities | — | — | — | -4,280USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.